# A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated

> **NCT05469646** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 1819479
- **DRUG:** Matching placebo

## Key facts

- **NCT ID:** NCT05469646
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-03
- **Primary completion:** 2022-12-20
- **Final completion:** 2022-12-27
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05469646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05469646, "A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05469646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*